Skip to main content
Premium Trial:

Request an Annual Quote

OraSure to Buy DNA Genotek for $53M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – OraSure Technologies announced after the close of the market on Monday that it is acquiring DNA Genotek for $53 million in cash.

The deal, which is expected to be completed in the third quarter, will provide OraSure, based in Bethlehem, Pa., with a complementary portfolio of products for the collection, stabilization, transportation, and storage of high quality nucleic acid samples, the company said.

It also provides OraSure, whose products include antibody-based assays for infectious diseases, with a presence in the molecular diagnostics space. In a statement, Douglas Michels, president and CEO of OraSure, said that his firm has "targeted entry into the US $4 billion molecular diagnostics market given the magnitude and rapid growth profile of the segment."

Headquartered in Ottawa, DNA Genotek develops products to collect, stabilize, and prepare oral fluid samples for molecular diagnostic applications. Its lead product is the Oragene DNA sample collection kit. The company is currently seeking clearance from the US Food and Drug Administration for Oragene products.

In 2010, DNA Genotek generated approximately $14 million in revenues, OraSure said.

It added that the acquisition is expected to be neutral to non-GAAP earnings, excluding transaction costs and required acquisition accounting adjustments, and to be accretive to revenue growth in 2012 and beyond. Following completion of the deal, DNA Genotek will operate as a wholly-owned subsidiary of OraSure.

Deutsche Bank Securities was the advisor to OraSure on the deal. Moelis & Co. advised DNA Genotek.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.